nach oben

Inflammation

Erschienen in:

16.09.2019 | Original Article

Protective Effect of Mitogen- and Stress-Activated Protein Kinase on the Rats with Focal Ischemia-Reperfusion Injury

verfasst von: Yanfeng Zhou, Guangzhong Gao, Zhen Li, Lin Jiang

Erschienen in: Inflammation | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Mitogen- and stress-activated protein kinase (MSK) is a recently identified nuclear cAMP-regulated enhancer B (CREB) and histone H3 kinase that responds to both mitogen- and stress-activated protein kinases. This study was designed to investigate the protective effect of MSK on the rats with focal ischemia-reperfusion injury. The rat model was established by inserting thread into the middle cerebral artery. The protein expression was measured by immunoblotting. The localization of MSK was measured by immunofluorescence assay. Highly-differentiated pheochromocytoma 12 (PC12) is used as a sympathetic neuron-like cell line and treated with glutamate to induce neurotoxicity. MSK was knocked down and overexpressed by siRNA and MSK over-expressing vector, respectively. The cell viability was measured by cell counting kit (CCK-8) assay. The coronal sections were isolated and stained with 2, 3, 5-triphenyltetrazolium chloride (TTC) to determine infarct volume. Finally, astrocytes were separated from cerebral cortexes of normal rats to analyze the effects of MSK on inflammatory response. In the rats with focal ischemia-reperfusion injury, the expression of MSK was reduced, reaching the lowest level at 3 d after ischemia-reperfusion, and then recovered gradually. MSK was found mainly localized in neurons and astrocytes. The expression levels of caspase-3, caspase-8, caspase-9, and INOS showed the opposite trend with respect to MSK. Further analysis showed that overexpression of MSK exerted a protective effect on glutamate-induced neurotoxicity through inhibiting apoptosis of PC12 cells, as well as decreased the infarct size in rat with focal ischemia-reperfusion injury. On the contrary, knockdown of MSK showed opposite results. Finally, MSK suppressed LPS-induced inflammatory response by decreasing the expression of inducible nitric oxide synthase (INOS) and increasing the expression of interleukin-10 (IL-10) in astrocytes from cerebral cortexes of normal rats. In conclusion, MSK exerted a protective effect on rat with focal ischemia-reperfusion injury through its anti-apoptotic effect on neurons and anti-inflammatory effect on astrocytes.

al Makdessi, S., H. Sweidan, K. Dietz, and R. Jacob. 1999. Protective effect of Crataegus oxyacantha against reperfusion arrhythmias after global no-flow ischemia in the rat heart. Basic Research in Cardiology 94 (2): 71–77.PubMedCrossRef

Bogoyevitch, M.A., J. Gillespie-Brown, A.J. Ketterman, S.J. Fuller, R. Ben-Levy, A. Ashworth, C.J. Marshall, and P.H. Sugden. 1996. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circulation Research 79 (2): 162–173. https://doi.org/10.1161/01.res.79.2.162.PubMedCrossRef

Cazes, E., J. Gironmichel, S. Baouz, C. Doucet, F. Cagnoni, S. Oddera, M. Körner, G. Dasic, R. Testi, and B. Azzarone. 2001. Novel anti-inflammatory effects of the inhaled corticosteroid fluticasone propionate during lung myofibroblastic differentiation. Journal of Immunology 167 (9): 5329–5337.CrossRef

Chao, J., H. Yin, Y.Y. Yao, B. Shen, R.S. Smith Jr., and L. Chao. 2006. Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation. Human Gene Therapy 17 (12): 1201–1213. https://doi.org/10.1089/hum.2006.17.1201.PubMedCrossRef

Deak, Maria, Andrew D. Clifton, John M. Lucocq, and Dario R. Alessi. 2014. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO Journal 17 (15): 4426–4441.CrossRef

Eltzschig, Holger K., and Tobias Eckle. 2011. Ischemia and reperfusion—from mechanism to translation. Nature Medicine 17 (11): 1391–1401.PubMedCrossRef

Fieschi, C., V. Di Piero, G.L. Lenzi, P. Pantano, F. Giubilei, C. Buttinelli, and A. Carolei. 1990. Pathophysiology of ischemic brain disease. Stroke 21 (12 Suppl): Iv9-11.PubMed

Furman, Jennifer L., Diana M. Sama, John C. Gant, Tina L. Beckett, M. Paul Murphy, Adam D. Bachstetter, Linda J. Van Eldik, and Christopher M. Norris. 2012. Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer’s disease. Journal of Neuroscience the Official Journal of the Society for Neuroscience 32 (46): 16129–16140.CrossRef

Galán-Ganga, Marcos, Ángel J. García-Yagüe, and Isabel Lastres-Becker. 2019. Role of MSK1 in the induction of NF-κB by the chemokine CX3CL1 in microglial cells. Cellular and Molecular Neurobiology 39 (3): 331–340. https://doi.org/10.1007/s10571-019-00664-w.PubMedCrossRef

10.

Hammer, M., J. Mages, H. Dietrich, A. Servatius, N. Howells, A.C. Cato, and R. Lang. 2006. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. The Journal of Experimental Medicine 203 (1): 15–20. https://doi.org/10.1084/jem.20051753.PubMedPubMedCentralCrossRef

11.

Heffron, Daniel, and James W. Mandell. 2005. Differential localization of MAPK-activated protein kinases RSK1 and MSK1 in mouse brain. Brain Research Molecular Brain Research 136 (1): 134–141.PubMedCrossRef

12.

Hesse, A.K., M. Dorger, C. Kupatt, and F. Krombach. 2004. Proinflammatory role of inducible nitric oxide synthase in acute hyperoxic lung injury. Respiratory Research 5: 11. https://doi.org/10.1186/1465-9921-5-11.PubMedPubMedCentralCrossRef

13.

Karelina, K., Y. Liu, D. Alzatecorrea, K.L. Wheaton, K.R. Hoyt, J.S. Arthur, and K. Obrietan. 2015. Mitogen and stress-activated kinases 1/2 regulate ischemia-induced hippocampal progenitor cell proliferation and neurogenesis. Neuroscience 285: 292–302.PubMedCrossRef

14.

Kim, Seung Hwan, Young Mo Yang, Young Rok Ha, Sung Pil Chung, In Sool Yoo, and In Byung Kim. 2001. Ischemia-responsive protein (irp94) gene expression in a neuronal cell culture model of ischemia. Journal of The Korean Society of Emergency Medicine 12 (3): 201–206.

15.

Klotz, L.O., K. Briviba, and H. Sies. 2000. Mitogen-activated protein kinase activation by singlet oxygen and ultraviolet a. Methods in Enzymology 319 (24): 130–143.PubMedCrossRef

16.

Lejay, Anne, Alain Meyer, Anna Isabel Schlagowski, Anne Laure Charles, François Singh, Jamal Bouitbir, Julien Pottecher, Nabil Chakfé, Joffrey Zoll, and Bernard Geny. 2014. Mitochondria: mitochondrial participation in ischemia–reperfusion injury in skeletal muscle. International Journal of Biochemistry & Cell Biology 50 (1): 101–105.CrossRef

17.

Li, X.Q., H.W. Lv, W.F. Tan, B. Fang, H. Wang, and H. Ma. 2014. Role of the TLR4 pathway in blood-spinal cord barrier dysfunction during the bimodal stage after ischemia/reperfusion injury in rats. Journal of Neuroinflammation 11: 62. https://doi.org/10.1186/1742-2094-11-62.PubMedPubMedCentralCrossRef

18.

Li, Zhen, Li Zhao, Huayun Hang, Ningxi Zhu, Bo Ning, and Zhengwen Lv. 2013. Spatiotemporal patterns and essential role of MSK1 expression after rat spinal cord injury. Neurochemical Research 38 (12): 2581–2587.PubMedCrossRef

19.

Lin, T.N., Y.Y. He, G. Wu, M. Khan, and C.Y. Hsu. 1993. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke; a Journal of Cerebral Circulation 24 (1): 117–121.CrossRef

20.

Longa, E.Z., P.R. Weinstein, S. Carlson, and R. Cummins. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1): 84–91.PubMedCrossRef

21.

Bakkebø, M., K. Huse, V.I. Hilden, E.B. Smeland, and M.P. Oksvold. 2010. TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK. BMC Immunology 11 (1): 1–10.CrossRef

22.

Mellidis, K., Dokalis N., Barlaka E., and Lazou A. 2014. P87 * activation of mitogen and stress activated kinase 1 (MSK1) during oxidative stress modulates apoptotic and autophagy pathways leading to cardioprotection.

23.

Milionis, H., and P. Michel. 2013. Acute ischemic cerebrovascular events on antiplatelet therapy: what is the optimal prevention strategy? Current Pharmaceutical Design 19 (21): 3788–3794.PubMedCrossRef

24.

Mitogen- and Stress-Activated Protein Kinase 1. 2012. In Encyclopedia of Signaling Molecules, ed. Sangdun Choi, 1081–1081. New York, NY: Springer New York.

25.

Monnet-Tschudi, F., M.G. Zurich, and P. Honegger. 2007. Neurotoxicant-induced inflammatory response in three-dimensional brain cell cultures. Human & Experimental Toxicology 26 (4): 339–346.CrossRef

26.

Ning, Bo, Geng Guo, Hong Liu, Lei Ning, Bao-Liang Sun, Zhen Li, Shuo Wang, Zheng-Wen Lv, and Cun-Dong Fan. 2017. MSK1 downregulation is associated with neuronal and astrocytic apoptosis following subarachnoid hemorrhage in rats. Oncology Letters 14 (3): 2940–2946.PubMedPubMedCentralCrossRef

27.

Olmez, Inan, and Huseyin Ozyurt. 2012. Reactive oxygen species and ischemic cerebrovascular disease. Neurochemistry International 60 (2): 208–212.PubMedCrossRef

28.

Perrelli, Maria Giulia, Pasquale Pagliaro, and Claudia Penna. 2011. Ischemia/reperfusion injury and cardioprotective mechanisms:Role of mitochondria and reactive oxygen species. World Journal of Cardiology 3 (6): 186–200.PubMedPubMedCentralCrossRef

29.

Turer, A.T., and J.A. Hill. 2010. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. The American Journal of Cardiology 106 (3): 360–368. https://doi.org/10.1016/j.amjcard.2010.03.032.PubMedPubMedCentralCrossRef

30.

Vermeulen, L., W. Vanden Berghe, I.M. Beck, K. De Bosscher, and G. Haegeman. 2009. The versatile role of MSKs in transcriptional regulation. Trends in Biochemical Sciences 34 (6): 311–318. https://doi.org/10.1016/j.tibs.2009.02.007.PubMedCrossRef

31.

Wiggin, G.R., A. Soloaga, J.M. Foster, V. Murray-Tait, P. Cohen, and J.S. Arthur. 2002. MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Molecular and Cellular Biology 22 (8): 2871–2881. https://doi.org/10.1128/mcb.22.8.2871-2881.2002.PubMedPubMedCentralCrossRef

32.

Yang, Guangtian, Chonghui Jiang, Yan Tang, and Peihua Wang. 2000. Effects of L-Tetrahydropalmatine on neuron apoptosis during acute cerebral ischemia-reperfusion of rats. Journal of Tongji Medical University 20 (2): 106–108.PubMedCrossRef

33.

Zhang, P., Y. Zhang, J. Zhang, Y. Wu, J. Jia, J. Wu, and Y. Hu. 2013. Early exercise protects against cerebral ischemic injury through inhibiting neuron apoptosis in cortex in rats. International Journal of Molecular Sciences 14 (3): 6074–6089.PubMedPubMedCentralCrossRef

Titel: Protective Effect of Mitogen- and Stress-Activated Protein Kinase on the Rats with Focal Ischemia-Reperfusion Injury
verfasst von: Yanfeng Zhou
Guangzhong Gao
Zhen Li
Lin Jiang
Publikationsdatum: 16.09.2019
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 6/2019
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-019-01080-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2019

Inhibiting microRNA-7 Expression Exhibited a Protective Effect on Intestinal Mucosal Injury in TNBS-Induced Inflammatory Bowel Disease Animal Model

SS31 Ameliorates Sepsis-Induced Heart Injury by Inhibiting Oxidative Stress and Inflammation

Role of JNK Signaling Pathway in Dexmedetomidine Post-Conditioning-Induced Reduction of the Inflammatory Response and Autophagy Effect of Focal Cerebral Ischemia Reperfusion Injury in Rats

Catalase S-Glutathionylation by NOX2 and Mitochondrial-Derived ROS Adversely Affects Mice and Human Neutrophil Survival

The Presence of High Levels of Circulating Trimethylamine N-Oxide Exacerbates Central and Peripheral Inflammation and Inflammatory Hyperalgesia in Rats Following Carrageenan Injection